OMVs have been engineered to display various proteins that aid in targeting them towards tumor cells, including programmed death-1 (PD-1) to target tumor cells overexpressing programmed death ligand-1 (PD-L1) in mouse models derived from B-16 melanoma and CT-26 colorectal cell lines. This evidence concerns the gene CD274 and melanoma.